Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.
Saved in:
| Title: | Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities. |
|---|---|
| Authors: | Piguet AC; Hepatology, Department of Clinical Research, University of Berne, Berne, Switzerland., Majumder S; †Vascular Biology Laboratory, Life Sciences Division, AU-KBC Research Centre, Anna University, Chennai, Tamil Nadu, India., Maheshwari U; †Vascular Biology Laboratory, Life Sciences Division, AU-KBC Research Centre, Anna University, Chennai, Tamil Nadu, India., Manjunathan R; †Vascular Biology Laboratory, Life Sciences Division, AU-KBC Research Centre, Anna University, Chennai, Tamil Nadu, India., Saran U; †Vascular Biology Laboratory, Life Sciences Division, AU-KBC Research Centre, Anna University, Chennai, Tamil Nadu, India., Chatterjee S; †Vascular Biology Laboratory, Life Sciences Division, AU-KBC Research Centre, Anna University, Chennai, Tamil Nadu, India., Dufour JF |
| Source: | Clinical science (London, England : 1979) [Clin Sci (Lond)] 2014 Jun; Vol. 126 (11), pp. 775-84. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model: Print Cited Medium: Internet ISSN: 1470-8736 (Electronic) Linking ISSN: 01435221 NLM ISO Abbreviation: Clin Sci (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1470-8736 |
|---|---|
| DOI: | 10.1042/CS20130081 |
